DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 21, 2004; DOI: 10.1124/dmd.104.000299


0090-9556/04/3210-1075-1082$20.00
DMD 32:1075-1082, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.000299v1
32/10/1075    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, C.
Right arrow Articles by Blumberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, C.
Right arrow Articles by Blumberg, B.

TOCOTRIENOLS ACTIVATE THE STEROID AND XENOBIOTIC RECEPTOR, SXR, AND SELECTIVELY REGULATE EXPRESSION OF ITS TARGET GENES

Changcheng Zhou, Michelle M. Tabb, Asal Sadatrafiei, Felix Grün, and Bruce Blumberg

Department of Developmental and Cell Biology, University of California, Irvine, California

Vitamin E is an essential nutrient with antioxidant activity. Vitamin E is comprised of eight members, {alpha}-, ß-, {gamma}-, and {delta}-tocopherols and {alpha}-, ß-, {gamma}-, and {delta}-tocotrienols. All forms of vitamin E are initially metabolized by {omega}-oxidation, which is catalyzed by cytochrome P450 enzymes. The steroid and xenobiotic receptor (SXR) is a nuclear receptor that regulates drug clearance in the liver and intestine via induction of genes involved in drug and xenobiotic metabolism. We show here that all four tocotrienols specifically bind to and activate SXR, whereas tocopherols neither bind nor activate. Surprisingly, tocotrienols show tissue-specific induction of SXR target genes, particularly CYP3A4. Tocotrienols up-regulate expression of CYP3A4 but not UDP-glucuronosyltransferase 1A1 (UGT1A1) or multidrug resistance protein-1 (MDR1) in primary hepatocytes. In contrast, tocotrienols induce MDR1 and UGT1A1 but not CYP3A4 expression in intestinal LS180 cells. We found that nuclear receptor corepressor (NCoR) is expressed at relatively high levels in intestinal LS180 cells compared with primary hepatocytes. The unliganded SXR interacts with NCoR, and this interaction is only partially disrupted by tocotrienols. Expression of a dominant-negative NCoR enhanced the ability of tocotrienols to induce CYP3A4 in LS180 cells, suggesting that NCoR plays an important role in tissue-specific gene regulation by SXR. Our findings provide a molecular mechanism explaining how vitamin supplements affect the absorption and effectiveness of drugs. Knowledge of drug-nutrient interactions may help reduce the incidence of decreased drug efficacy.


Address correspondence to: Dr. Bruce Blumberg, Department of Developmental and Cell Biology, University of California, 5205 McGaugh Hall, Irvine, CA 92697-2300. E-mail: blumberg{at}uci.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
V. Chu, H. J. Einolf, R. Evers, G. Kumar, D. Moore, S. Ripp, J. Silva, V. Sinha, M. Sinz, and A. Skerjanec
In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective
Drug Metab. Dispos., July 1, 2009; 37(7): 1339 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Harmsen, A. S. Koster, J. H. Beijnen, J. H. M. Schellens, and I. Meijerman
Comparison of Two Immortalized Human Cell Lines to Study Nuclear Receptor-Mediated CYP3A4 Induction
Drug Metab. Dispos., June 1, 2008; 36(6): 1166 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. Akaho, J. Takata, T. Fukushima, K. Matsunaga, A. Hattori, R. Hidaka, K. Fukui, M. Yoshida, T. Fujioka, Y. Karube, et al.
Preparation and In Vivo Evaluation of a Water-Soluble Prodrug for 2R-{gamma}-Tocotrienol and as a Two-Step Prodrug for 2,7,8-Trimethyl-2S-({beta}-carboxyethyl)-6-hydroxychroman (S-{gamma}-CEHC) in Rat
Drug Metab. Dispos., September 1, 2007; 35(9): 1502 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Ekins, C. Chang, S. Mani, M. D. Krasowski, E. J. Reschly, M. Iyer, V. Kholodovych, N. Ai, W. J. Welsh, M. Sinz, et al.
Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
Mol. Pharmacol., September 1, 2007; 72(3): 592 - 603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. G Traber
Heart disease and single-vitamin supplementation
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 293S - 299S.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Zhou, E.-J. Poulton, F. Grun, T. K. Bammler, B. Blumberg, K. E. Thummel, and D. L. Eaton
The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear Receptor
Mol. Pharmacol., January 1, 2007; 71(1): 220 - 229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-L. Song and R. A. DeBose-Boyd
Insig-dependent Ubiquitination and Degradation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Stimulated by {delta}- and {gamma}-Tocotrienols
J. Biol. Chem., September 1, 2006; 281(35): 25054 - 25061.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
I. Meijerman, J. H. Beijnen, and J. H.M. Schellens
Herb-Drug Interactions in Oncology: Focus on Mechanisms of Induction
Oncologist, July 1, 2006; 11(7): 742 - 752.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Miki, T. Suzuki, K. Kitada, N. Yabuki, R. Shibuya, T. Moriya, T. Ishida, N. Ohuchi, B. Blumberg, and H. Sasano
Expression of the Steroid and Xenobiotic Receptor and Its Possible Target Gene, Organic Anion Transporting Polypeptide-A, in Human Breast Carcinoma
Cancer Res., January 1, 2006; 66(1): 535 - 542.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Mani, H. Huang, S. Sundarababu, W. Liu, G. Kalpana, A. B. Smith, and S. B. Horwitz
Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents
Clin. Cancer Res., September 1, 2005; 11(17): 6359 - 6369.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. W. Leonard, E. Gumpricht, M. W. Devereaux, R. J. Sokol, and M. G. Traber
Quantitation of rat liver vitamin E metabolites by LC-MS during high-dose vitamin E administration
J. Lipid Res., May 1, 2005; 46(5): 1068 - 1075.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.